Shanghai Shen Lian Biomedical Corp Strategic Asset Allocation Index
Shanghai Shen Lian Biomedical Corp strategic asset allocation index. Shanghai Shen Lian Biomedical Corp (688098) has a Strategic Asset Allocation Index of 53.1% as of June 2023. Strategic assets (PP&E of CN¥782.78 Million plus long-term investments of CN¥-) total CN¥782.78 Million, measured against net assets of CN¥1.47 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Shanghai Shen Lian Biomedical Corp (688098) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shanghai Shen Lian Biomedical Corp (2016–2022)
Strategic asset allocation index of Shanghai Shen Lian Biomedical Corp from 2016 to 2022. This chart shows how Shanghai Shen Lian Biomedical Corp's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 53.1%, representing strategic assets of CN¥782.78 Million against net assets of CN¥1.47 Billion CNY.
Shanghai Shen Lian Biomedical Corp Strategic Asset Allocation Index by Year (2016–2022)
Shanghai Shen Lian Biomedical Corp strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Shen Lian Biomedical Corp from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 688098 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 51.9% | CN¥776.66 Million | CN¥776.66 Million | CN¥- | CN¥1.50 Billion | ▼ -0.3 pp |
| 2021 | 52.2% | CN¥768.55 Million | CN¥768.55 Million | CN¥- | CN¥1.47 Billion | ▲ +6.1 pp |
| 2020 | 46.0% | CN¥642.76 Million | CN¥642.76 Million | CN¥- | CN¥1.40 Billion | ▲ +3.3 pp |
| 2019 | 42.7% | CN¥546.94 Million | CN¥546.94 Million | CN¥- | CN¥1.28 Billion | ▼ -13.3 pp |
| 2018 | 56.0% | CN¥465.63 Million | CN¥465.63 Million | CN¥- | CN¥831.94 Million | ▼ -10.7 pp |
| 2017 | 66.7% | CN¥366.26 Million | CN¥366.26 Million | CN¥- | CN¥549.27 Million | ▲ +1.4 pp |
| 2016 | 65.3% | CN¥303.83 Million | CN¥303.83 Million | CN¥- | CN¥465.47 Million | — |